Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas

L. A. Jones, C. L. Edwards, R. S. Freedman, M. T. Tan, H. S. Gallager

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Only 69% (42 of 61) of the documentated ovarian tumor specimens received between September 1981 and August 1982 contained 75% or more viable tumor. Of the 42 measured for estrogen receptors (ER) and progesterone receptors (PR), 34 (81%) had estrogen‐binding titers. ⩾1 fmol/mg of cytosol protein, while 18 (43%) had progesterone‐binding titers ⩾5 fmol/mg of cytosol protein. ER and PR titers were found to be independent of histologic grade, clinical stage, patient age, age at first pregnancy, age at menarche, age at menopause and number of pregnancies. The presence of ER and PR in malignant ovarian tumors suggests that assays positive for these hormones could aid in the selection of patients suitable for hormonal therapy.

Original languageEnglish (US)
Pages (from-to)567-571
Number of pages5
JournalInternational journal of cancer
Volume32
Issue number5
DOIs
StatePublished - Nov 15 1983

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas'. Together they form a unique fingerprint.

Cite this